Mastl/PP2A regulate Cdk1 in ooycte maturation
Mastl/PP2A regulate Cdk1 in ooycte maturation |
https://doi.org/10.18632/oncotarget.4916
Deepak Adhikari,
Kui Liu,
and Philipp Kaldis
|
18734-18735 |
FPRs: linking innate immune system and fibrosis
FPRs: linking innate immune system and fibrosis |
https://doi.org/10.18632/oncotarget.4915
Francesca Wanda Rossi,
and Nunzia Montuori
|
18736-18737 |
Scribble dictates orderly stem cell fate
Scribble dictates orderly stem cell fate |
https://doi.org/10.18632/oncotarget.4923
Ryo Fujita,
Daiki Seko,
and Yusuke Ono
|
18738-18739 |
Fragments and hot spots in drug discovery
Fragments and hot spots in drug discovery |
https://doi.org/10.18632/oncotarget.4968
Sandor Vajda,
Adrian Whitty,
and Dima Kozakov
|
18740-18741 |
A bacterial toxin that cleaves Ras oncoprotein
A bacterial toxin that cleaves Ras oncoprotein |
https://doi.org/10.18632/oncotarget.5113
Marco Biancucci,
and Karla J.F. Satchell
|
18742-18743 |
Antimicrobial peptides targeting bacterial ribosome
Antimicrobial peptides targeting bacterial ribosome |
https://doi.org/10.18632/oncotarget.5114
Ivan B. Lomakin,
Matthieu G. Gagnon,
and Thomas A. Steitz
|
18744-18745 |
Unexpected insights for anti-EGFR cancer therapy
Unexpected insights for anti-EGFR cancer therapy |
https://doi.org/10.18632/oncotarget.5115
Philippe Depeille,
Robert S. Warren,
and Jeroen P. Roose
|
18746-18747 |
Targeting cancer by binding iron: Dissecting cellular signaling pathways
Targeting cancer by binding iron: Dissecting cellular signaling pathways |
https://doi.org/10.18632/oncotarget.4349
Goldie Y.L. Lui,
Zaklina Kovacevic,
Vera Richardson,
Angelica M. Merlot,
Danuta S. Kalinowski,
and Des R. Richardson
|
18748-18779 |
MYC-repressed long noncoding RNAs antagonize MYC-induced cell proliferation and cell cycle progression
MYC-repressed long noncoding RNAs antagonize MYC-induced cell proliferation and cell cycle progression |
https://doi.org/10.18632/oncotarget.3909
Taewan Kim,
Ri Cui,
Young-Jun Jeon,
Paolo Fadda,
Hansjuerg Alder,
and Carlo M. Croce
|
18780-18789 |
Bmk-1 regulates lifespan in Caenorhabditis elegans by activating hsp-16
Bmk-1 regulates lifespan in Caenorhabditis elegans by activating hsp-16 |
https://doi.org/10.18632/oncotarget.4618
Hong Qian,
Xiangru Xu,
and Laura E. Niklason
|
18790-18799 |
Differential modulation of AMPK/PPARα/UCP2 axis in relation to hypertension and aging in the brain, kidneys and heart of two closely related spontaneously hypertensive rat strains
Differential modulation of AMPK/PPARα/UCP2 axis in relation to hypertension and aging in the brain, kidneys and heart of two closely related spontaneously hypertensive rat strains |
https://doi.org/10.18632/oncotarget.4033
Speranza Rubattu,
Franca Bianchi,
Carla Letizia Busceti,
Maria Cotugno,
Rosita Stanzione,
Simona Marchitti,
Sara Di Castro,
Michele Madonna,
Ferdinando Nicoletti,
and Massimo Volpe
|
18800-18818 |
Evidence for the involvement of sphingosine-1-phosphate in the homing and engraftment of hematopoietic stem cells to bone marrow
Evidence for the involvement of sphingosine-1-phosphate in the homing and engraftment of hematopoietic stem cells to bone marrow |
https://doi.org/10.18632/oncotarget.4710
Mateusz Adamiak,
Sylwia Borkowska,
Marcin Wysoczynski,
Malwina Suszynska,
Magda Kucia,
Gregg Rokosh,
Ahmed Abdel-Latif,
Janina Ratajczak,
and Mariusz Z. Ratajczak
|
18819-18828 |
Inhibition of microRNA-497 ameliorates anoxia/reoxygenation injury in cardiomyocytes by suppressing cell apoptosis and enhancing autophagy
Inhibition of microRNA-497 ameliorates anoxia/reoxygenation injury in cardiomyocytes by suppressing cell apoptosis and enhancing autophagy |
https://doi.org/10.18632/oncotarget.4774
Xixian Li,
Zhi Zeng,
Qingman Li,
Qiulin Xu,
Jiahe Xie,
Huixin Hao,
Guangjin Luo,
Wangjun Liao,
Jianping Bin,
Xiaobo Huang,
and Yulin Liao
|
18829-18844 |
Integration of microarray analysis into the clinical diagnosis of hematological malignancies: How much can we improve cytogenetic testing?
Integration of microarray analysis into the clinical diagnosis of hematological malignancies: How much can we improve cytogenetic testing? |
https://doi.org/10.18632/oncotarget.4586
Jess F. Peterson,
Nidhi Aggarwal,
Clayton A. Smith,
Susanne M. Gollin,
Urvashi Surti,
Aleksandar Rajkovic,
Steven H. Swerdlow,
and Svetlana A. Yatsenko
|
18845-18862 |
Phospho-T356RB1 predicts survival in HPV-negative squamous cell carcinoma of the head and neck
Phospho-T356RB1 predicts survival in HPV-negative squamous cell carcinoma of the head and neck |
https://doi.org/10.18632/oncotarget.4321
Tim N. Beck,
John Kaczmar,
Elizabeth Handorf,
Anna Nikonova,
Cara Dubyk,
Suraj Peri,
Miriam Lango,
John A. Ridge,
Ilya G. Serebriiskii,
Barbara Burtness,
Erica A. Golemis,
and Ranee Mehra
|
18863-18874 |
The PARP inhibitor olaparib enhances the sensitivity of Ewing sarcoma to trabectedin
The PARP inhibitor olaparib enhances the sensitivity of Ewing sarcoma to trabectedin |
https://doi.org/10.18632/oncotarget.4303
José Luis Ordóñez,
Ana Teresa Amaral,
Angel M. Carcaboso,
David Herrero-Martín,
María del Carmen García-Macías,
Vicky Sevillano,
Diego Alonso,
Guillem Pascual-Pasto,
Laura San-Segundo,
Monica Vila-Ubach,
Telmo Rodrigues,
Susana Fraile,
Cristina Teodosio,
Agustín Mayo-Iscar,
Miguel Aracil,
Carlos María Galmarini,
Oscar M. Tirado,
Jaume Mora,
and Enrique de Álava
|
18875-18890 |
Increased expression of fatty acid synthase provides a survival advantage to colorectal cancer cells via upregulation of cellular respiration
Increased expression of fatty acid synthase provides a survival advantage to colorectal cancer cells via upregulation of cellular respiration |
https://doi.org/10.18632/oncotarget.3783
Yekaterina Y. Zaytseva,
Jennifer W. Harris,
Mihail I. Mitov,
Ji Tae Kim,
D. Allan Butterfield,
Eun Y. Lee,
Heidi L. Weiss,
Tianyan Gao,
and B. Mark Evers
|
18891-18904 |
Underexpression of LKB1 tumor suppressor is associated with enhanced Wnt signaling and malignant characteristics of human intrahepatic cholangiocarcinoma
Underexpression of LKB1 tumor suppressor is associated with enhanced Wnt signaling and malignant characteristics of human intrahepatic cholangiocarcinoma |
https://doi.org/10.18632/oncotarget.4305
Jinghan Wang,
Keqiang Zhang,
Jinhui Wang,
Xiwei Wu,
Xiyong Liu,
Bin Li,
Yan Zhu,
Yong Yu,
Qingbao Cheng,
Zhenli Hu,
Chao Guo,
Shuya Hu,
Bing Mu,
Chun-Hao Tsai,
Jie Li,
Lynne Smith,
Lu Yang,
Qi Liu,
Peiguo Chu,
Vincent Chang,
Baihe Zhang,
Mengchao Wu,
Xiaoqing Jiang,
and Yun Yen
|
18905-18920 |
Small molecule inhibitor screen identifies synergistic activity of the bromodomain inhibitor CPI203 and bortezomib in drug resistant myeloma
Small molecule inhibitor screen identifies synergistic activity of the bromodomain inhibitor CPI203 and bortezomib in drug resistant myeloma |
https://doi.org/10.18632/oncotarget.4214
Matthew B. Siegel,
Selina Qiuying Liu,
Monika A. Davare,
Stephen E. Spurgeon,
Marc M. Loriaux,
Brian J. Druker,
Emma C. Scott,
and Jeffrey W. Tyner
|
18921-18932 |
microRNA-4717 differentially interacts with its polymorphic target in the PD1 3’ untranslated region: A mechanism for regulating PD-1 expression and function in HBV-associated liver diseases
microRNA-4717 differentially interacts with its polymorphic target in the PD1 3’ untranslated region: A mechanism for regulating PD-1 expression and function in HBV-associated liver diseases |
https://doi.org/10.18632/oncotarget.3662
Guoyu Zhang,
Na Li,
Zhu Li,
Qianqian Zhu,
Fang Li,
Cuiling Yang,
Qunying Han,
Yi Lv,
Zhihua Zhou,
and Zhengwen Liu
|
18933-18944 |
Impact of systemic targeted agents on the clinical outcomes of patients with brain metastases
Impact of systemic targeted agents on the clinical outcomes of patients with brain metastases |
https://doi.org/10.18632/oncotarget.4153
Adam G. Johnson,
Jimmy Ruiz,
Ryan Hughes,
Brandi R. Page,
Scott Isom,
John T. Lucas,
Emory R. McTyre,
Kristin W. Houseknecht,
Diandra N. Ayala-Peacock,
J. Daniel Bourland,
William H. Hinson,
Adrian W. Laxton,
Stephen B. Tatter,
Waldemar Debinski,
Kounosuke Watabe,
and Michael D. Chan
|
18945-18955 |
Targeting IRAK1 in T-cell acute lymphoblastic leukemia
Targeting IRAK1 in T-cell acute lymphoblastic leukemia |
https://doi.org/10.18632/oncotarget.4150
Charles Dussiau,
Amélie Trinquand,
Ludovic Lhermitte,
Mehdi Latiri,
Mathieu Simonin,
Agata Cieslak,
Nawel Bedjaoui,
Patrick Villarèse,
Els Verhoeyen,
Hervé Dombret,
Norbert Ifrah,
Elizabeth Macintyre,
and Vahid Asnafi
|
18956-18965 |
Role and prognostic significance of the epithelial-mesenchymal transition factor ZEB2 in ovarian cancer
Role and prognostic significance of the epithelial-mesenchymal transition factor ZEB2 in ovarian cancer |
https://doi.org/10.18632/oncotarget.3943
Silvia Prislei,
Enrica Martinelli,
Gian Franco Zannoni,
Marco Petrillo,
Flavia Filippetti,
Marisa Mariani,
Simona Mozzetti,
Giuseppina Raspaglio,
Giovanni Scambia,
and Cristiano Ferlini
|
18966-18979 |
MicroRNA-106b inhibits osteoclastogenesis and osteolysis by targeting RANKL in giant cell tumor of bone
MicroRNA-106b inhibits osteoclastogenesis and osteolysis by targeting RANKL in giant cell tumor of bone |
https://doi.org/10.18632/oncotarget.4223
Ting Wang,
Huabin Yin,
Jing Wang,
Zhenxi Li,
Haifeng Wei,
Zhi’an Liu,
Zhipeng Wu,
Wangjun Yan,
Tielong Liu,
Dianwen Song,
Xinghai Yang,
Quan Huang,
Wang Zhou,
and Jianru Xiao
|
18980-18996 |
The predictive value of ERCC1 and p53 for the effect of panobinostat and cisplatin combination treatment in NSCLC
The predictive value of ERCC1 and p53 for the effect of panobinostat and cisplatin combination treatment in NSCLC |
https://doi.org/10.18632/oncotarget.3620
Yang Cai,
Xiang Yan,
Guoqing Zhang,
Weihong Zhao,
and Shunchang Jiao
|
18997-19005 |
miR-17 regulates melanoma cell motility by inhibiting the translation of ETV1
miR-17 regulates melanoma cell motility by inhibiting the translation of ETV1 |
https://doi.org/10.18632/oncotarget.4147
Ronit Cohen,
Eyal Greenberg,
Yael Nemlich,
Jacob Schachter,
and Gal Markel
|
19006-19016 |
SNP interactions of Helicobacter pylori-related host genes PGC, PTPN11, IL1B, and TLR4 in susceptibility to gastric carcinogenesis
SNP interactions of Helicobacter pylori-related host genes PGC, PTPN11, IL1B, and TLR4 in susceptibility to gastric carcinogenesis |
https://doi.org/10.18632/oncotarget.4231
Caiyun He,
Huakang Tu,
Liping Sun,
Qian Xu,
Yuehua Gong,
Jingjing Jing,
Nannan Dong,
and Yuan Yuan
|
19017-19026 |
Nitroxoline impairs tumor progression in vitro and in vivo by regulating cathepsin B activity
Nitroxoline impairs tumor progression in vitro and in vivo by regulating cathepsin B activity |
https://doi.org/10.18632/oncotarget.3699
Bojana Mirković,
Boštjan Markelc,
Miha Butinar,
Ana Mitrović,
Izidor Sosič,
Stanislav Gobec,
Olga Vasiljeva,
Boris Turk,
Maja Čemažar,
Gregor Serša,
and Janko Kos
|
19027-19042 |
miR-1238 inhibits cell proliferation by targeting LHX2 in non-small cell lung cancer
miR-1238 inhibits cell proliferation by targeting LHX2 in non-small cell lung cancer |
https://doi.org/10.18632/oncotarget.4232
Xiangguang Shi,
Lei Zhan,
Can Xiao,
Zhe Lei,
Haiping Yang,
Longqiang Wang,
Jun Zhao,
and Hong-Tao Zhang
|
19043-19054 |
Gα12 overexpressed in hepatocellular carcinoma reduces microRNA-122 expression via HNF4α inactivation, which causes c-Met induction
Gα12 overexpressed in hepatocellular carcinoma reduces microRNA-122 expression via HNF4α inactivation, which causes c-Met induction |
https://doi.org/10.18632/oncotarget.3957
Yoon Mee Yang,
Chan Gyu Lee,
Ja Hyun Koo,
Tae Kim Kim,
Jung Min Lee,
Jihyun An,
Kang Mo Kim,
and Sang Geon Kim
|
19055-19069 |
Identification and characterization of the gene expression profiles for protein coding and non-coding RNAs of pancreatic ductal adenocarcinomas
Identification and characterization of the gene expression profiles for protein coding and non-coding RNAs of pancreatic ductal adenocarcinomas |
https://doi.org/10.18632/oncotarget.4233
María Laura Gutiérrez,
Luis Corchete,
Cristina Teodosio,
María Eugenia Sarasquete,
María del Mar Abad,
Manuel Iglesias,
Carmen Esteban,
José María Sayagues,
Alberto Orfao,
and Luis Muñoz-Bellvis
|
19070-19086 |
A novel HMGA1-CCNE2-YAP axis regulates breast cancer aggressiveness
A novel HMGA1-CCNE2-YAP axis regulates breast cancer aggressiveness |
https://doi.org/10.18632/oncotarget.4236
Silvia Pegoraro,
Gloria Ros,
Yari Ciani,
Riccardo Sgarra,
Silvano Piazza,
and Guidalberto Manfioletti
|
19087-19101 |
The SIRT1/TP53 axis is activated upon B-cell receptor triggering via miR-132 up-regulation in chronic lymphocytic leukemia cells
The SIRT1/TP53 axis is activated upon B-cell receptor triggering via miR-132 up-regulation in chronic lymphocytic leukemia cells |
https://doi.org/10.18632/oncotarget.3905
Michele Dal Bo,
Tiziana D’Agaro,
Stefania Gobessi,
Antonella Zucchetto,
Sara Dereani,
Davide Rossi,
Francesco Zaja,
Gabriele Pozzato,
Francesco Di Raimondo,
Gianluca Gaidano,
Luca Laurenti,
Giovanni Del Poeta,
Dimitar G. Efremov,
Valter Gattei,
and Riccardo Bomben
|
19102-19117 |
MUC16-mediated activation of mTOR and c-Myc reprograms pancreatic cancer metabolism
MUC16-mediated activation of mTOR and c-Myc reprograms pancreatic cancer metabolism |
https://doi.org/10.18632/oncotarget.4078
Surendra K. Shukla,
Venugopal Gunda,
Jaime Abrego,
Dhanya Haridas,
Anusha Mishra,
Joshua Souchek,
Nina V. Chaika,
Fang Yu,
Aaron R. Sasson,
Audrey J. Lazenby,
Surinder K. Batra,
and Pankaj K. Singh
|
19118-19131 |
Integrated analysis of microRNAs, transcription factors and target genes expression discloses a specific molecular architecture of hyperdiploid multiple myeloma
Integrated analysis of microRNAs, transcription factors and target genes expression discloses a specific molecular architecture of hyperdiploid multiple myeloma |
https://doi.org/10.18632/oncotarget.4302
Maria Teresa Di Martino,
Pietro Hiram Guzzi,
Daniele Caracciolo,
Luca Agnelli,
Antonino Neri,
Brian A. Walker,
Gareth J. Morgan,
Mario Cannataro,
Pierfrancesco Tassone,
and Pierosandro Tagliaferri
|
19132-19147 |
Protein phosphatase PHLPP induces cell apoptosis and exerts anticancer activity by inhibiting Survivin phosphorylation and nuclear export in gallbladder cancer
Protein phosphatase PHLPP induces cell apoptosis and exerts anticancer activity by inhibiting Survivin phosphorylation and nuclear export in gallbladder cancer |
https://doi.org/10.18632/oncotarget.3721
Yinghe Qiu,
Xiaoya Li,
Bin Yi,
Junnian Zheng,
Zhangxiao Peng,
Zhihan Zhang,
Mengchao Wu,
Feng Shen,
and Changqing Su
|
19148-19162 |
Continuous representation of tumor microvessel density and detection of angiogenic hotspots in histological whole-slide images
Continuous representation of tumor microvessel density and detection of angiogenic hotspots in histological whole-slide images |
https://doi.org/10.18632/oncotarget.4383
Jakob Nikolas Kather,
Alexander Marx,
Constantino Carlos Reyes-Aldasoro,
Lothar R. Schad,
Frank Gerrit Zöllner,
and Cleo-Aron Weis
|
19163-19176 |
Targeting lactate transport suppresses in vivo breast tumour growth
Targeting lactate transport suppresses in vivo breast tumour growth |
https://doi.org/10.18632/oncotarget.3910
Filipa Morais-Santos,
Sara Granja,
Vera Miranda-Gonçalves,
António H.J. Moreira,
Sandro Queirós,
João L. Vilaça,
Fernando C. Schmitt,
Adhemar Longatto-Filho,
Joana Paredes,
Fátima Baltazar,
and Céline Pinheiro
|
19177-19189 |
GPER agonist G-1 decreases adrenocortical carcinoma (ACC) cell growth in vitro and in vivo
GPER agonist G-1 decreases adrenocortical carcinoma (ACC) cell growth in vitro and in vivo |
https://doi.org/10.18632/oncotarget.4241
Adele Chimento,
Rosa Sirianni,
Ivan Casaburi,
Fabiana Zolea,
Pietro Rizza,
Paola Avena,
Rocco Malivindi,
Arianna De Luca,
Carmela Campana,
Emilia Martire,
Francesco Domanico,
Francesco Fallo,
Giulia Carpinelli,
Lidia Cerquetti,
Donatella Amendola,
Antonio Stigliano,
and Vincenzo Pezzi
|
19190-19203 |
Classification and clinical behavior of blastic plasmacytoid dendritic cell neoplasms according to their maturation-associated immunophenotypic profile
Classification and clinical behavior of blastic plasmacytoid dendritic cell neoplasms according to their maturation-associated immunophenotypic profile |
https://doi.org/10.18632/oncotarget.4146
Lourdes Martín-Martín,
Antonio López,
Belén Vidriales,
María Dolores Caballero,
António Silva Rodrigues,
Silvia Inês Ferreira,
Margarida Lima,
Sérgio Almeida,
Berta Valverde,
Pilar Martínez,
Ana Ferrer,
Jorge Candeias,
Francisco Ruiz-Cabello,
Josefa Marco Buadesa,
Amparo Sempere,
Neus Villamor,
Alberto Orfao,
and Julia Almeida
|
19204-19216 |
Elevated preoperative aspartate aminotransferase to lymphocyte ratio index as an independent prognostic factor for patients with hepatocellular carcinoma after hepatic resection
Elevated preoperative aspartate aminotransferase to lymphocyte ratio index as an independent prognostic factor for patients with hepatocellular carcinoma after hepatic resection |
https://doi.org/10.18632/oncotarget.4265
Junfei Jin,
Pengpeng Zhu,
Yan Liao,
Jun Li,
Weijia Liao,
and Songqing He
|
19217-19227 |
The presence of wild type p53 in hematological cancers improves the efficacy of combinational therapy targeting metabolism
The presence of wild type p53 in hematological cancers improves the efficacy of combinational therapy targeting metabolism |
https://doi.org/10.18632/oncotarget.4653
Nerea Allende-Vega,
Ewelina Krzywinska,
Stefania Orecchioni,
Nuria Lopez-Royuela,
Francesca Reggiani,
Giovanna Talarico,
Jean-François Rossi,
Rodrigue Rossignol,
Yosr Hicheri,
Guillaume Cartron,
Francesco Bertolini,
and Martin Villalba
|
19228-19245 |
Circulating small non coding RNA signature in head and neck squamous cell carcinoma
Circulating small non coding RNA signature in head and neck squamous cell carcinoma |
https://doi.org/10.18632/oncotarget.4266
Berta Victoria Martinez,
Joseph M. Dhahbi,
Yury O. Nunez Lopez,
Katarzyna Lamperska,
Paweł Golusinski,
Lukasz Luczewski,
Tomasz Kolenda,
Hani Atamna,
Stephen R. Spindler,
Wojciech Golusinski,
and Michal M. Masternak
|
19246-19263 |
Mucin1 promotes the migration and invasion of hepatocellular carcinoma cells via JNK-mediated phosphorylation of Smad2 at the C-terminal and linker regions
Mucin1 promotes the migration and invasion of hepatocellular carcinoma cells via JNK-mediated phosphorylation of Smad2 at the C-terminal and linker regions |
https://doi.org/10.18632/oncotarget.4267
Juan Wang,
Guomu Liu,
Qiongshu Li,
Fang Wang,
Fei Xie,
Ruiping Zhai,
Yingying Guo,
Tanxiu Chen,
Nannan Zhang,
Weihua Ni,
Hongyan Yuan,
and Guixiang Tai
|
19264-19278 |
Tracking sub-clonal TP53 mutated tumor cells in human metastatic renal cell carcinoma
Tracking sub-clonal TP53 mutated tumor cells in human metastatic renal cell carcinoma |
https://doi.org/10.18632/oncotarget.4220
Guilhem Bousquet,
Morad El Bouchtaoui,
Christophe Leboeuf,
Maxime Battistella,
Mariana Varna,
Irmine Ferreira,
Louis-François Plassa,
Diaddin Hamdan,
Philippe Bertheau,
Jean-Paul Feugeas,
Diane Damotte,
and Anne Janin
|
19279-19289 |
Infiltrating neutrophils promote renal cell carcinoma progression via VEGFa/HIF2α and estrogen receptor β signals
Infiltrating neutrophils promote renal cell carcinoma progression via VEGFa/HIF2α and estrogen receptor β signals |
https://doi.org/10.18632/oncotarget.4478
Wenbin Song,
Chiuan-Ren Yeh,
Dalin He,
Yong Wang,
Hongjun Xie,
See-Tong Pang,
Luke Sien-Shih Chang,
Lei Li,
and Shuyuan Yeh
|
19290-19304 |
Impact of VEGF, VEGFR, PDGFR, HIF and ERCC1 gene polymorphisms on thymic malignancies outcome after thymectomy
Impact of VEGF, VEGFR, PDGFR, HIF and ERCC1 gene polymorphisms on thymic malignancies outcome after thymectomy |
https://doi.org/10.18632/oncotarget.4191
Rossana Berardi,
Alessandro Brunelli,
Silvia Pagliaretta,
Vittorio Paolucci,
Alessandro Conti,
Gaia Goteri,
Majed Refai,
Cecilia Pompili,
Giulia Marcantognini,
Francesca Morgese,
Zelmira Ballatore,
Agnese Savini,
Mariagrazia De Lisa,
Miriam Caramanti,
Matteo Santoni,
Antonio Zizzi,
Francesco Piva,
Paola Mazzanti,
Azzurra Onofri,
Armando Sabbatini,
Marina Scarpelli,
and Stefano Cascinu
|
19305-19315 |
Predictors of early treatment discontinuation in patients enrolled on Phase I oncology trials
Predictors of early treatment discontinuation in patients enrolled on Phase I oncology trials |
https://doi.org/10.18632/oncotarget.2909
David M. Hyman,
Anne A. Eaton,
Mrinal M. Gounder,
Erika G. Pamer,
Jasmine Pettiford,
Richard D. Carvajal,
S. Percy Ivy,
Alexia Iasonos,
and David R. Spriggs
|
19316-19327 |
Detection of high mobility group A2 specific mRNA in the plasma of patients affected by epithelial ovarian cancer
Detection of high mobility group A2 specific mRNA in the plasma of patients affected by epithelial ovarian cancer |
https://doi.org/10.18632/oncotarget.2896
Francesca Galdiero,
Annunciata Romano,
Rosa Pasquinelli,
Sandro Pignata,
Stefano Greggi,
Emilia Vuttariello,
Anna Maria Bello,
Celeste Calise,
Cono Scaffa,
Carmela Pisano,
Nunzia Simona Losito,
Alfredo Fusco,
Daniela Califano,
and Gennaro Chiappetta
|
19328-19335 |